drugset / Trial / NCT02698995

Perineural Low-dose Dexamethasone Added to Infraclavicular Block Anesthesia

NCT02698995

Phase 3 Completed 180 enrolled Foisor Orthopedics Clinical Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Dexamethasone has an evidence-based indication in postoperative emesis prophylaxy and as a antiinflammatory steroid. Although the perineural administration is off-label, several studies recognised its analgetic action as an adjuvant for peripheral nerves blockade, permitting to reduce the concentration of the local anesthetics and extending the sensory and motor block.Questions remain concerning the mechanism of action, optimal dose, the lack/degree of toxicity and the comparison with intravenous administration.The aim of this prospective randomized controlled study is to investigate the efficacy of analgesia with 4 mg or 2 mg Dexamethasone added to a combination of ropivacaine 0,5% and lidocaine 1% in vertical infraclavicular blockade (VIB) anesthesia for upper limb surgery.

Timeline

Start
2015-11
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 2 mg Other
Comparator Dexamethasone Small molecule 4 mg Other
Comparator Acetaminophen Small molecule 1 g Intravenous
Comparator Lidocaine Other / unclassified 100 mg Other
Comparator Morphine Other / unclassified 2 mg Intravenous
Comparator Ropivacaine Other / unclassified 100 mg Other

Indications

No indication recorded.